Myeloma Clinician Scientist πŸ”¬πŸ’ŠπŸ‘©πŸ»β€πŸ”¬πŸ‘©πŸ»β€βš•οΈ

Joined December 2012
104 Photos and videos
Sad that @EHA_Hematology #CRTH2024 is coming to an end this week but looking forward to 2025 - please consider applying to join us!
4
20
2,680
Charlotte Pawlyn retweeted
What is ⁦@EHA_Hematology⁩ Clinical Research Training in #Hematology (CRTH)? #CRTH provides early-career researchers with a unique, 9-month long training and mentoring experience. The CRTH 2025 call for applications is open until August 30, 2024 search.app/383eipgfnc8AdXth7
4
17
2,411
Charlotte Pawlyn retweeted
πŸ“£ Our Early Career Advancement Fellowships are officially open for applications! πŸ“£ These awards will support the brightest and best early career blood cancer researchers as they begin their journey to independence. Full details on our website bloodcancer.org.uk/research/…
1
9
10
2,229
Charlotte Pawlyn retweeted
.@mvmateos makes a very important point - Frailty score is dynamic! It’s important to reassess frailty- bone pain and renal impairment may change with treatment. Frailty is not one and done. #mmsm #EHA2024
5
14
1,171
Charlotte Pawlyn retweeted
From learning new #clinicaltrial skills to developing your own research project, #EHA Clinical Research Training in Hematology (#CRTH) is a chance to advance your #hematology career. Hear from C Lecat, past CRTH scholar about her experience πŸ‘‡ Learn more: eha.fyi/CRTH25
4
12
2,219
We are looking for a new consultant colleague (10 PA, substantive NHS post). Great opportunity for anyone with an interest in myeloma who wants to join an academic centre. royalmarsden.nhs.uk/current-…

3
6
10
1,844
There will be opportunities to contribute to T- cell directed therapy service expansion and be involved in / lead clinical research - working with a great team! Feel free to free to contact me for further information or apply at link above.
1
731
Great new tool for patients presented by @MyelomaEurope at #EMN2024
1
1
9
540
Great session at #EMN2024 from patient organisations @IMFmyeloma and @MyelomaEurope
11
577
Charlotte Pawlyn retweeted
Not sure if you can submit an abstract and join #EHA2024? If you are under 36, you may qualify for a travel or participation grant. Grant applications are available during regular abstract submission and close on March 1, 2024. Submit an abstract: eha.fyi/EHA2024_abstracts
5
5
2,474
Presenting the work of Dr Yigen Li from my lab @ICR_London at #ASH2023
3
23
2,167
Exciting initial HRQoL data from the FiTNEss trial. @CTRUmyeloma @profBigG @profghjackson @LeedsCTRU
2
2
27
1,793
Should have added @kennycairns @Orla_McCourt 😊
1
221
#MyXAnniversary joined at #ASH2012 ….now at #ASH2023
2
316
Charlotte Pawlyn retweeted
28 Sep 2023
Protein shake! Amazing talk by @apwiita on Proteomics to ID new MM targets. Poss source of biomarkers / classification of disease. Can use protein β€œSurfaceome” to ID new targets /protein conformation differences specific to MM plasma cells for targeting #mmsm #IMS23 @UCSFCancer
7
22
2,115
Charlotte Pawlyn retweeted
27 Sep 2023
B cells gone Bad… aberrant B cell differentiation as the origin of MM. 1q abnormalities detectable in pt B cells β€”> implications for FCRL5 Congratulations to Wen Zhou for this work and #IMS23 abstract prize ! #mmsm
3
17
1,680
Charlotte Pawlyn retweeted
πŸ“’ On #EuropeanMyelomaDay, our goal is to highlight the crucial importance of early diagnosis for better patient outcomes. 24% of patients will wait 5 months or more to get a #myeloma diagnosis. Learn more here: mpeurope.org/2023/09/27/24-o…
1
12
19
2,695
Charlotte Pawlyn retweeted
Today is #EuropeanMyelomaDay! MPE launched this effort to spotlight the needs of patients like Vincent Claus and tackle issues such as delayed diagnosis. Watch the video to see how myeloma affects lives and learn how you can be part of the change. #LearnShareChange
4
3
1,380
Charlotte Pawlyn retweeted
27 Sep 2023
Problematic Progenitors: awesome work by @Dr_Rodg showing that MM relapse may be driven by B cells & pre-plasma cells. One of my fave abstracts this am, as I am convinced that the β€œMM stem cell” is the πŸ”‘ to cure #IMS23 #mmsm
3
3
15
1,546
Outstanding plenary talk by Dr Peter Campbell highlighting complexity of mutational burden, T cell clones and selection pressures that inform clonal heterogeneity of in cancer - we have a lot to learn still about clinical/therapeutic implications in #mmsm #IMS23 - job is not done yet.
10
48
3,632